Literature DB >> 7046734

Distribution of beta-endorphin-related peptides in rat pituitary and brain.

S Zakarian, D G Smyth.   

Abstract

beta-Endorphin, the most potent known naturally occurring analgesic agent, is found in pituitary and brain in company with a series of structurally and biosynthetically related peptides that are essentially devoid of opiate activity. In studies of beta-endorphin it is important to discriminate between the active and inactive forms of the peptide. This review describes the use of chemical and immunological methods for localizing the peptides in the tissues, extracting and resolving the peptides by chromatography, and determining the concentrations of the peptides by radioimmunoassay. These approaches have allowed the distribution of beta-endorphin and its related peptides to be assigned unequivocally in regions of rat pituitary and brain. It has been found that the multifunctional corticotropin-endorphin prohormone can undergo processing by different mechanisms in different tissues, permitting the intrinsic activities of its fragments to be expressed selectively. The different processing patterns can be attributed to the existence of highly specific enzymes, characteristic of individual cells, which regulate the formation of this potent opiate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7046734      PMCID: PMC1158149          DOI: 10.1042/bj2020561

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

1.  A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties.

Authors:  B M Cox; K E Opheim; H Teschemacher; A Goldstein
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

2.  An endogenous morphine-like factor in mammalian brain.

Authors:  G W Pasternak; R Goodman; S H Snyder
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

3.  Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine.

Authors:  J Hughes
Journal:  Brain Res       Date:  1975-05-02       Impact factor: 3.252

4.  Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands.

Authors:  C H Li; D Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

Review 5.  The evolution of vertebrate corticotrophin and melanocyte stimulating hormone.

Authors:  P J Lowry; A P Scott
Journal:  Gen Comp Endocrinol       Date:  1975-05       Impact factor: 2.822

6.  C fragment of lipotropin has a high affinity for brain opiate receptors.

Authors:  N J Birdsall; E C Hulme
Journal:  Nature       Date:  1976-04-29       Impact factor: 49.962

Review 7.  Proteolytic processing in the biosynthesis of insulin and other proteins.

Authors:  D F Steiner; W Kemmler; H S Tager; J D Peterson
Journal:  Fed Proc       Date:  1974-10

8.  Isolation and amino-acid sequence of beta-LPH from sheep pituitary glands.

Authors:  C H Li; L Barnafi; M Chrétien; D Chung
Journal:  Nature       Date:  1965-12-11       Impact factor: 49.962

9.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

10.  Adrenocorticotrophic and melanocyte-stimulating peptides in the human pituitary.

Authors:  A P Scott; P J Lowry
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

View more
  11 in total

1.  Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens.

Authors:  Nesrin Filiz Basaran; R Levent Buyukuysal; William R Millington; Sinan Cavun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

2.  Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.

Authors:  M Hong; M Sutak; K Jhamandas
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

Review 3.  Endogenous opioids and excessive alcohol consumption.

Authors:  C Gianoulakis
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

4.  Monoclonal antibody to the message sequence Tyr-Gly-Gly-Phe of opioid peptides exhibits the specificity requirements of mammalian opioid receptors.

Authors:  T Meo; C Gramsch; R Inan; V Höllt; E Weber; A Herz; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

Review 5.  Signaling mechanisms of μ-opioid receptor (MOR) in the hippocampus: disinhibition versus astrocytic glutamate regulation.

Authors:  Min-Ho Nam; Woojin Won; Kyung-Seok Han; C Justin Lee
Journal:  Cell Mol Life Sci       Date:  2020-07-15       Impact factor: 9.261

Review 6.  The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.

Authors:  Kabirullah Lutfy; Nurulain T Zaveri
Journal:  Prog Mol Biol Transl Sci       Date:  2015-12-23       Impact factor: 3.622

Review 7.  Genetics of alcoholism: role of the endogenous opioid system.

Authors:  C Gianoulakis; J P de Waele
Journal:  Metab Brain Dis       Date:  1994-06       Impact factor: 3.584

8.  Determination of β-Endorphin and Fragments Thereof in Human Plasma Using High-Performance Liquid Chromatography and a Multiple Radioimmunoassay System.

Authors:  K Wiedemann; H Teschemacher
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

Review 9.  The effect of ethanol on the biosynthesis and regulation of opioid peptides.

Authors:  C Gianoulakis
Journal:  Experientia       Date:  1989-05-15

Review 10.  The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential.

Authors:  Johannes Burtscher; Christoph Schwarzer
Journal:  Front Mol Neurosci       Date:  2017-08-07       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.